Literature DB >> 25437731

Diagnosis and surgical treatment of stress urinary incontinence.

Alan D Garely1, Nabila Noor.   

Abstract

Stress urinary incontinence (SUI) is a major problem affecting more than 20% of the nation's female population, with increasing prevalence as our population continues to age. Incontinence places a great burden on individuals, and the economic effect is large. Stress urinary incontinence occurs when there is involuntary leakage of urine during coughing, laughing, sneezing, or physical activity. It can be diagnosed during physical examination and by using low-cost office diagnostics. Although nonsurgical treatments provide some benefit, surgical interventions have demonstrated superiority with respect to subjective and objective cure and better long-term improvement. Corrective surgeries for SUI can be grouped into four categories: 1) slings (midurethral slings and slings placed at the ureterovesical junction), 2) retropubic urethropexy, 3) urethral bulking agents, and 4) artificial sphincters. The success and failure of each approach needs to be assessed in the context of individual patients and their circumstances. Slings and retropubic urethropexy are considered first-line surgical options. Since the advent of minimally invasive retropubic midurethral slings such as the tension-free vaginal tape, transobturator tension-free vaginal tape, and single-incision sling, retropubic urethropexy have fallen out of favor. Warnings about mesh use may contribute to a resurgence of retropubic urethropexy procedures such as the Burch procedure. A Burch procedure should still be considered for patients who have an aversion to mesh or if they are undergoing concurrent abdominal approach surgery. Urethral bulking agents are usually reserved for patients with a fixed, nonmobile urethra who cannot tolerate an operative experience or have failed previous antiincontinence procedures. Artificial sphincters should be considered an operation of last resort.

Entities:  

Mesh:

Year:  2014        PMID: 25437731     DOI: 10.1097/AOG.0000000000000514

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Anatomic relation between single-incision slings and the obturator vessels.

Authors:  Amy L O'Boyle; Christopher P Chung; Wilma Larsen
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

Review 2.  Cystourethroscopy following midurethral slings: is it always necessary?

Authors:  Jerome Melon; Erin C Kelly; Kim W M van Delft
Journal:  Int Urogynecol J       Date:  2018-03-21       Impact factor: 2.894

3.  A randomized, nonblinded extension study of single-incision versus transobturator midurethral sling in women with stress urinary incontinence.

Authors:  René P Schellart; Sandra E Zwolsman; Jean-Philippe Lucot; Dirk J M K de Ridder; Marcel G W Dijkgraaf; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2017-06-02       Impact factor: 2.894

4.  A randomised comparison of single-incision versus traditional transobturator midurethral sling in women with stress urinary incontinence: results of a 24-month follow-up.

Authors:  René P Schellart; Katrien Oude Rengerink; Frank Van der Aa; Jean-Philippe Lucot; Bart Kimpe; Marcel G W Dijkgraaf; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2015-12-15       Impact factor: 2.894

5.  Influence of age, BMI and parity on the success rate of midurethral slings for stress urinary incontinence.

Authors:  Rosa Maria Laterza; Ksenia Halpern; Daniela Ulrich; Alexandra Graf; Karl Tamussino; Wolfgang Umek
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

6.  Urinary proteomic pattern in female stress urinary incontinence: a pilot study.

Authors:  Marianne Koch; Goran Mitulovic; Engelbert Hanzal; Wolfgang Umek; Sonja Seyfert; Thomas Mohr; Heinz Koelbl; Rosa Maria Laterza
Journal:  Int Urogynecol J       Date:  2016-05-18       Impact factor: 2.894

7.  Long-term re-procedure rate after mid-urethral slings for stress urinary incontinence.

Authors:  Sari Tulokas; Päivi Rahkola-Soisalo; Mika Gissler; Tomi S Mikkola; Maarit J Mentula
Journal:  Int Urogynecol J       Date:  2020-01-20       Impact factor: 2.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.